Showing 1 - 10 of 617
Persistent link: https://www.econbiz.de/10003212049
The recent withdrawal of Cox-2 Inhibitors has generated debate on the role of information in drug diffusion: can the market learn the efficacy of new drugs, or does it depend solely on manufacturer advertising and FDA updates? In this study, we use a novel data set to study the diffusion of...
Persistent link: https://www.econbiz.de/10012464395
Markets that involve customers waiting for services or goods in queues whose length they cannot observe are studied. In these markets suppliers truncate queues that become so long that they jeopardize the supplier's future relations with the customer. The length of the queue and the probability...
Persistent link: https://www.econbiz.de/10012475056
Alan Garber and Jonathan Skinner (2008) famously conjectured that the US health care system was "uniquely inefficient" relative to other countries. We test this idea using cross-country data on prescription drug sales newly linked with an arguably objective measure of relative therapeutic...
Persistent link: https://www.econbiz.de/10012455612
The US Food and Drug Administration (FDA) expends considerable efforts in regulating medications approved for use. Yet the impact of medication labeling changes on brand pharmaceutical products, and whether and what firms do to respond to increased information regarding the safety and efficacy...
Persistent link: https://www.econbiz.de/10012461130
We report results from the first randomization of a regulatory reform in the health sector. The reform established minimum quality standards for patient safety, an issue that has become increasingly salient following the Ebola and COVID-19 epidemics. In our experiment, all 1348 health facilities...
Persistent link: https://www.econbiz.de/10014287304
Persistent link: https://www.econbiz.de/10013480767
Prior studies suggest that, with elastically supplied inputs, free entry may lead to an inefficiently high number of firms in equilibrium. Under input scarcity, however, the welfare loss from free entry is reduced. Further, free entry may increase use of high-quality inputs, as oligopolistic...
Persistent link: https://www.econbiz.de/10012463435
There are ongoing debates around the world over the value of private supplements to public health insurance systems. We investigate this issue in the context of one of the world's deadliest diseases, diabetes, and one of the countries with the worst diabetes problems in the world, Mexico. We...
Persistent link: https://www.econbiz.de/10012585397
The aim of this paper is to assess the impact of the Community Health Center (CHC) on health levels in the U.S. Using infant mortality as the underlying health indicator, a time series of large counties as the data set, and multivariate regression techniques, we investigate the extent to which...
Persistent link: https://www.econbiz.de/10012478085